<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Bioorg Med Chem Lett</journal-id>
      <journal-title-group>
        <journal-title>Bioorganic &amp; Medicinal Chemistry Letters</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0960-894X</issn>
      <issn pub-type="epub">1464-3405</issn>
      <publisher>
        <publisher-name>Elsevier Science Ltd</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2957807</article-id>
      <article-id pub-id-type="pmid">20462758</article-id>
      <article-id pub-id-type="publisher-id">BMCL15806</article-id>
      <article-id pub-id-type="doi">10.1016/j.bmcl.2010.04.079</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis and biological activity of α-<sc>l</sc>-fucosyl ceramides, analogues of the potent agonist, α-<sc>d</sc>-galactosyl ceramide KRN7000</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Veerapen</surname>
            <given-names>Natacha</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reddington</surname>
            <given-names>Faye</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bricard</surname>
            <given-names>Gabriel</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Porcelli</surname>
            <given-names>Steven A.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">b</xref>
          <xref rid="aff3" ref-type="aff">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Besra</surname>
            <given-names>Gurdyal S.</given-names>
          </name>
          <email>g.besra@bham.ac.uk</email>
          <xref rid="aff1" ref-type="aff">a</xref>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK</aff>
      <aff id="aff2"><label>b</label>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA</aff>
      <aff id="aff3"><label>c</label>Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Tel.: +44 (0)121 4158125. <email>g.besra@bham.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>6</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>6</month>
        <year>2010</year>
      </pub-date>
      <volume>20</volume>
      <issue>11</issue>
      <fpage>3223</fpage>
      <lpage>3226</lpage>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>4</month>
          <year>2010</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>4</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>4</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2010 Elsevier Ltd.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Ltd</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <title>Graphical abstract</title>
        <p>The synthesis of α-<sc>l</sc>-fucosyl ceramide derivatives and their biological evaluation is described.</p>
      </abstract>
      <abstract>
        <p>Several <sc>l</sc>-fucoglycolipids are associated with diseases such as cancer, cystic fibrosis and rheumatoid arthritis. Activation of <italic>i</italic>NKT cells is known to lead to the production of cytokines that can help alleviate or exacerbate these conditions. α-Galactosyl ceramide (α-GalCer) is a known agonist of <italic>i</italic>NKT cells and it is believed that its fucosyl counterpart might have similar immunogenic properties. We herein report the synthesis of α-<sc>l</sc>-fucosyl ceramide derivatives and describe their biological evaluation. The key challenge in the synthesis of the target molecules involved the stereoselective synthesis of the α-glycosidic linkage. Of the methods examined, the per-TMS-protected glycosyl iodide donor was completely α-selective, and could be scaled up to provide gram quantities of the azide precursor <bold>11</bold>, from which a range of N-acylated α-<sc>l</sc>-fucosyl ceramides were readily obtained and evaluated for ex vivo expansion of human <italic>i</italic>NKT cells.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>CD1d</kwd>
        <kwd><italic>i</italic>NKT</kwd>
        <kwd>Antigen</kwd>
        <kwd>Ceramide</kwd>
        <kwd>Lipid</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Both <sc>d</sc>- and <sc>l</sc>-fucose (6-deoxy galactose) are widely found in nature.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> Of interest, <sc>l</sc>-fucose is predominantly found in the α-configuration in the lipopolysaccharides (LPS) of Gram-negative bacteria and animal glycosphingolipids.<xref rid="bib1 bib2" ref-type="bibr"><sup>1,2</sup></xref> With the exception of the monohexylceramide, α-<sc>l</sc>-fucosylceramide <bold>1</bold>, initially isolated from metastatic human adenocarcinoma,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> most fucosphingolipids are usually ceramide oligosaccharides.<xref rid="bib2 bib4" ref-type="bibr"><sup>2,4</sup></xref> Many of these fucolipids are antigenic<xref rid="bib5 bib6 bib7" ref-type="bibr"><sup>5–7</sup></xref> and play a role in tumour cell biology.<xref rid="bib8 bib9 bib10" ref-type="bibr"><sup>8–10</sup></xref> Conversely, the synthetic glycolipid, α-galactosyl ceramide (α-GalCer)<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> (<bold>2</bold>), is a strong agonist of <italic>i</italic>NKT cells when bound to CD1d, triggering the release of diverse cytokines, including both Th1 and Th2 cytokines.<xref rid="bib12 bib13 bib14" ref-type="bibr"><sup>12–14</sup></xref> It is believed that the release of Th1 cytokines may contribute to antitumour and antimicrobial functions while that of Th2 cytokines may help alleviate autoimmune diseases<xref rid="bib15 bib16 bib17" ref-type="bibr"><sup>15–17</sup></xref> such as multiple sclerosis<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> and arthritis.<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref><fig id="d30e341"><graphic xlink:href="fx2"/></fig></p>
    <p>α-GalCer and its derivatives have proved to be and remain invaluable tools in understanding the functioning of CD1d and <italic>i</italic>NKT cells in a wide range of immune responses. Crystal structures of the bound α-GalCer–CD1d complex<xref rid="bib20 bib21 bib22" ref-type="bibr"><sup>20–22</sup></xref> showed that the hydroxyl group at C-6 in the sugar head is not crucial for binding to the T-cell receptor (TCR) as opposed to C-2, C-3 and C-4. Hence, the α-<sc>d</sc>-fucosylceramide <bold>3</bold><xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> was shown to be a potent inducer of IFN-γ in mice in vivo, while a slightly different derivative, synthesised by Motoki et al.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> showed strong lymphocytic proliferation stimulatory effects in vitro in mice.</p>
    <p>While there are a few examples describing the synthesis of α-<sc>l</sc>-fucosylceramide <bold>4b</bold><xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> and other derivatives in the literature,<xref rid="bib26 bib27" ref-type="bibr"><sup>26,27</sup></xref> their biological activities are yet to be fully explored. As part of various ongoing studies, and because of the aforementioned reasons, we have synthesised compounds <bold>4a</bold>–<bold>4d</bold> for biological evaluation and comparative studies.<fig id="d30e388"><graphic xlink:href="fx3"/></fig></p>
    <p>Fan et al.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> reported the synthesis of compound <bold>4d</bold>, while Okamoto et al.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> reported that of compound <bold>4e</bold>. Both groups obtained their target compounds as an α, β mixture (3:1 ratio) from different glycosyl donors and acceptors (<xref rid="fig2" ref-type="fig">Scheme 1</xref>). On the other hand, in the original reported synthesis of the fucosylceramide <bold>1</bold>, only the α-anomer was isolated when another ceramide acceptor was used under different reaction conditions.</p>
    <p>We recently reported the synthesis<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> of α-GalCer and other derivatives where we used <italic>N</italic>-iodosuccinimide (NIS) and triflic acid (TfOH) as a promoter, and benzoate protecting groups on the sphingosine base. Along with the nature of the protecting groups on both the glycosyl acceptor and donor, the choice of promoter, as well as temperature and reaction times can affect the stereoselectivity of the glycosylation reaction. In this study, we proposed to investigate whether our glycosyl acceptor <bold>7</bold> and reaction conditions could offer a better α-selectivity in the case of <sc>l</sc>-fucose.</p>
    <p>The phytosphingosine acceptor <bold>7</bold><xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> was synthesised from (2<italic>S</italic>,3<italic>S</italic>,4<italic>R</italic>)-2-azido-1,3,4-octadecanetriol<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> as described before. Given the previous success of a thiogalactoside in a similar glycosylation reaction with compound <bold>7</bold><xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> we chose to use the thiofucosyl donor <bold>6</bold>, rather than compound <bold>5</bold>. The thioglycoside <bold>6</bold> was thus obtained from commercially available <sc>l</sc>-fucose after standard procedures, as previously reported.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref></p>
    <p>With both the acceptor and donor in hand, we then proceeded to the critical glycosylation reaction. Interestingly, NIS/TfOH activation of 1 g of the thioglycoside <bold>6</bold> (<xref rid="fig3" ref-type="fig">Scheme 2</xref>) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> at −78 °C afforded the glycosylated compound <bold>8</bold>, almost exclusively as the α-anomer (α:β ratio = 9:1), in 68% yield after 2 h. Our results show a definite improvement in selectivity from the previously reported syntheses. Because the formation of the α-anomer is favoured by the anomeric effect, we rationalise that the latter is a governing factor under our reaction conditions. Both the lower temperature and the different reactivity of the acceptor <bold>7</bold> could potentially influence the stereoselectivity of the glycosylation reaction. These factors will have to be more thoroughly investigated in a later study. Subsequent Zemplen’s deprotection of the benzoate protecting groups produced the azide intermediate in quantitative yields. Tandem hydrogenation of the azido group and hydrogenolysis of the benzyl ethers in methanol then produced the amine <bold>9</bold> as a white solid, which exhibited spectroscopic data consistent with the literature.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref></p>
    <p>In an attempt to improve the stereoselectivity and circumvent the sometimes problematic removal of the benzyl ethers by hydrogenolysis, we embarked on a different glycosylation route. Recently, the use of glycosyl iodide donors has been revived by Gervay-Hague’s group.<xref rid="bib32 bib33" ref-type="bibr"><sup>32,33</sup></xref> They have demonstrated that glycosylation reactions employing glycosyl iodides and promoted by tetrabutyl ammonium iodide (TBAI) are generally quite stereoselective and fast. It has been hypothesized that TBAI catalyses the isomerization of the α-glycosyl iodide to the β-anomer,<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> thereby leading to the formation of an α-glycoside. They have successfully adapted this strategy to the synthesis of α-GalCer<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and other α-fucosylglycosides.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Furthermore, the replacement of the benzyl ethers with trimethylsilylethers (TMS) made Gervay-Hague’s synthetic strategy even more attractive. TMS protected sugars are easy to generate and their deprotection requires very mild acidic conditions, compatible with the glycosidic linkage.</p>
    <p>The per-<italic>O</italic>-trimethylsilyl-α-<sc>l</sc>-fucosylpyranosyl iodide <bold>10</bold> was generated by the reaction of the per-<italic>O</italic>-tetramethylsilyl-α-<sc>l</sc>-fucose with one equivalent of iodotrimethylsilane<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and then added to the phytosphingosine acceptor <bold>7</bold> which was premixed with diisopropylethylamine (DIPEA) and TBAI (<xref rid="fig4" ref-type="fig">Scheme 3</xref>). After 2 days at room temperature, the solvent was evaporated and the TMS protecting groups were removed by treatment with an acidic resin in MeOH. Compound <bold>11</bold> was obtained as the α-anomer exclusively in an overall yield of 62%. The formation of the desired α-linkage was confirmed by the H-1 and C-1 signals in <sup>1</sup>H and <sup>13</sup>C NMR. Methanolysis, followed by hydrogenation of the azide then afforded compound <bold>9</bold>.</p>
    <p>Finally, N-acylation with the fully saturated fatty acids, tetracosanoic acid (C24:0) and hexacosanoic acid (C26:0), was achieved via reaction of the corresponding acid chloride with the free amine <bold>9</bold> in a 1:1 mixture of THF and saturated sodium acetate solution (<xref rid="fig4" ref-type="fig">Scheme 3</xref>). Target compounds <bold>4c</bold> and <bold>4d</bold> were obtained as white solids after concentration of the organic phase and purification of the residue by flash chromatography. The spectroscopic data of the final compounds were consistent with the literature.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> While compound <bold>4a</bold> was obtained by heating amine <bold>9</bold> with the <italic>N</italic>-hydroxysuccinimide activated ester of C20:2 fatty acid in a mixture of pyridine: water (9:1) at 50 °C overnight, compound <bold>4b</bold> was obtained via dicyclohexylcarbodiimide (DCC) activated coupling using procedures described previously.<xref rid="bib37 bib38" ref-type="bibr"><sup>37,38</sup></xref></p>
    <p>To assess the biological activity of the α-<sc>l</sc>-fucosylceramides and compare these to α-GalCer (KRN7000, <bold>2</bold>), we assessed the ability of each compound to induce the expansion of <italic>i</italic>NKT cells in samples of human peripheral blood mononuclear cells (PBMC) during an eight-day in vitro culture.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> The results showed that both the percentages and absolute numbers of <italic>i</italic>NKT cells in cultures were increased by stimulation with α-<sc>l</sc>-fucosylceramides with C26:0 (<bold>4d</bold>) &gt; C18:0 (OH) (<bold>4b</bold>) &gt; C24:0 (<bold>4c</bold>). The α-<sc>l</sc>-fucosylceramide containing a C26:0 fatty acid (<bold>4d</bold>) was the most active of the fucosyl series, and stimulated <italic>i</italic>NKT cell expansions in some donors that approached those seen with the prototype <italic>i</italic>NKT cell agonist KRN7000 (<bold>2</bold>). In contrast, the α-<sc>l</sc>-fucosylceramide containing the C20:2 fatty acid (<bold>4a</bold>) was found to lack detectable <italic>i</italic>NKT cell stimulating activity in any of the donors tested (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B). Representative profiles obtained by flow cytometry of cultures from one normal blood donor are shown in <xref rid="fig1" ref-type="fig">Figure 1</xref>A. This analysis was carried out with PBMC from four separate donors (<xref rid="fig1" ref-type="fig">Fig. 1</xref>B). Although, differences were observed for the levels of <italic>i</italic>NKT cell expansion between different donors, all donors responded significantly to two of the α-<sc>l</sc>-fucosylceramide analogues (<bold>4b</bold> and <bold>4d</bold>).</p>
    <p>In summary, in the current study we have developed an efficient method for the synthesis of a series of biologically active α-<sc>l</sc>-fucosylceramides.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> The second method, employing the per-<italic>O</italic>-trimethylsilyl-α-<sc>l</sc>-fucosylpyranosyl iodide <bold>10</bold>, proved to be superior with a better α-selectivity and reasonably good yield in the glycosylation reaction. Given the marked difference in the stereochemistry of the α-fucosyl head group of these glycolipids compared to α-galactosyl group of strong <italic>i</italic>NKT cell activators like KRN7000, it is surprising that the compounds in the current series show such substantial activity. This would seem to further reinforce the notion that the TCR of <italic>i</italic>NKT cells, in spite of its relative limited variability, is nevertheless able to interact efficiently with a broad range of structurally diverse ligands. It is noteworthy that the C20:2 <italic>N</italic>-acyl variant of α-fucosylceramide (<bold>4a</bold>) showed no detectable <italic>i</italic>NKT cell stimulating activity, given that the α-galactosyl version of this compound is an extremely potent <italic>i</italic>NKT cell agonist.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> This suggests that modification of the carbohydrate moiety can significantly alter the influence of the lipid moiety of the ligand on CD1d presentation and <italic>i</italic>NKT cell responses. Although the mechanism for this remains unclear, it is an important consideration for synthetic strategies that seek to combine biologically active alterations of the carbohydrate and lipid moieties of <italic>i</italic>NKT cell ligands.</p>
  </body>
  <back>
    <ref-list>
      <title>References and notes</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flowers</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Adv. Carbohydr. Chem. Biochem.</source>
          <volume>39</volume>
          <year>1981</year>
          <fpage>279</fpage>
          <pub-id pub-id-type="pmid">7025594</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vanhooren</surname>
              <given-names>P.T.</given-names>
            </name>
            <name>
              <surname>Vandamme</surname>
              <given-names>E.J.</given-names>
            </name>
          </person-group>
          <source>J. Chem. Technol. Biotechnol.</source>
          <volume>74</volume>
          <year>1999</year>
          <fpage>479</fpage>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watanabe</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hakomori</surname>
              <given-names>S.-I.</given-names>
            </name>
          </person-group>
          <source>J. Biol. Chem.</source>
          <volume>251</volume>
          <year>1976</year>
          <fpage>2385</fpage>
          <pub-id pub-id-type="pmid">1262328</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hakomori</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <source>Adv. Cancer Res.</source>
          <volume>52</volume>
          <year>1978</year>
          <fpage>257</fpage>
          <pub-id pub-id-type="pmid">2662714</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kannagi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Fukushi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tachikawa</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Noda</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shigeta</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hiraiwa</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Inamoto</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hakomori</surname>
              <given-names>S.-I.</given-names>
            </name>
            <name>
              <surname>Imura</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <source>Cancer Res.</source>
          <volume>46</volume>
          <year>1986</year>
          <fpage>2619</fpage>
          <pub-id pub-id-type="pmid">3008996</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magnani</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Steplewski</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Koprowski</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ginsburg</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <source>Cancer Res.</source>
          <volume>43</volume>
          <year>1983</year>
          <fpage>5489</fpage>
          <pub-id pub-id-type="pmid">6193872</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singhal</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Orntoft</surname>
              <given-names>T.F.</given-names>
            </name>
            <name>
              <surname>Nudelman</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Nance</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schibig</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Stroud</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Clausen</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hakomori</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <source>Cancer Res.</source>
          <volume>50</volume>
          <year>1990</year>
          <fpage>1375</fpage>
          <pub-id pub-id-type="pmid">2302702</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hakomori</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nudelman</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Levery</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Kannagi</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <source>J. Biol. Chem.</source>
          <volume>259</volume>
          <year>1984</year>
          <fpage>4672</fpage>
          <pub-id pub-id-type="pmid">6707026</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hattori</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Uemura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Taketomi</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <source>Biochim. Biophys. Acta</source>
          <volume>666</volume>
          <year>1981</year>
          <fpage>361</fpage>
          <pub-id pub-id-type="pmid">6798995</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hattori</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Uemura</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ogata</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Katsuyama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Taketomi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kanfer</surname>
              <given-names>J.N.</given-names>
            </name>
          </person-group>
          <source>Cancer Res.</source>
          <volume>47</volume>
          <year>1987</year>
          <fpage>1968</fpage>
          <pub-id pub-id-type="pmid">3815386</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawano</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Koezuka</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Toura</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Motoki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Koseki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Science</source>
          <volume>278</volume>
          <year>1997</year>
          <fpage>1626</fpage>
          <pub-id pub-id-type="pmid">9374463</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crowe</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Uldrich</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Kyparissoudis</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>K.J.L.</given-names>
            </name>
            <name>
              <surname>Hayakawa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sidobre</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Keating</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Godfrey</surname>
              <given-names>D.I.</given-names>
            </name>
          </person-group>
          <source>J. Immunol.</source>
          <volume>171</volume>
          <year>2003</year>
          <fpage>4020</fpage>
          <pub-id pub-id-type="pmid">14530322</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burdin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Brossay</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Eur. J. Immunol.</source>
          <volume>29</volume>
          <year>1999</year>
          <fpage>2014</fpage>
          <pub-id pub-id-type="pmid">10382765</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carnaud</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Donnars</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Beavis</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Koezuka</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bendelac</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <source>J. Immunol.</source>
          <volume>163</volume>
          <year>1999</year>
          <fpage>4647</fpage>
          <pub-id pub-id-type="pmid">10528160</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taniguchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kojo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Wakao</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <source>Annu. Rev. Immnunol.</source>
          <volume>21</volume>
          <year>2003</year>
          <fpage>483</fpage>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Godfrey</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>H.R.</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Van</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <source>Nat. Rev. Immunol.</source>
          <volume>4</volume>
          <year>2004</year>
          <fpage>231</fpage>
          <pub-id pub-id-type="pmid">15039760</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Aseguinolaza</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Van Kaer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bergmann</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Schmieg</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nakayama</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Koezuka</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>J. Exp. Med.</source>
          <volume>195</volume>
          <year>2002</year>
          <fpage>617</fpage>
          <pub-id pub-id-type="pmid">11877484</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yamamura</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <source>Nature</source>
          <volume>413</volume>
          <year>2001</year>
          <fpage>513</fpage>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiba</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Oki</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yamamura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <source>Arthritis Rheum.</source>
          <volume>50</volume>
          <year>2004</year>
          <fpage>305</fpage>
          <pub-id pub-id-type="pmid">14730629</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zajonc</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Cantu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mattner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Savage</surname>
              <given-names>P.B.</given-names>
            </name>
            <name>
              <surname>Bendelac</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>I.A.</given-names>
            </name>
            <name>
              <surname>Teyton</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <source>Nat. Immunol.</source>
          <volume>6</volume>
          <year>2005</year>
          <fpage>810</fpage>
          <pub-id pub-id-type="pmid">16007091</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koch</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stronge</surname>
              <given-names>V.S.</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gadola</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Mathew</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Fersht</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Besra</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>R.R.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>E.Y.</given-names>
            </name>
            <name>
              <surname>Cerundolo</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <source>Nat. Immunol.</source>
          <volume>6</volume>
          <year>2005</year>
          <fpage>819</fpage>
          <pub-id pub-id-type="pmid">16007090</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borg</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Wun</surname>
              <given-names>K.S.</given-names>
            </name>
            <name>
              <surname>Kjer-Nielsen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wilce</surname>
              <given-names>M.C.J.</given-names>
            </name>
            <name>
              <surname>Pellicci</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Besra</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Bharadwaj</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Godfrey</surname>
              <given-names>D.I.</given-names>
            </name>
            <name>
              <surname>McCluskey</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rossjohn</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Nature</source>
          <volume>448</volume>
          <year>2007</year>
          <fpage>44</fpage>
          <pub-id pub-id-type="pmid">17581592</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tashiro</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Shiozaki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Watarai</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron Lett.</source>
          <volume>49</volume>
          <year>2008</year>
          <fpage>6827</fpage>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motoki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Akimoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Koezuka</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <source>Biol. Pharm. Bull.</source>
          <volume>18</volume>
          <year>1995</year>
          <fpage>1487</fpage>
          <pub-id pub-id-type="pmid">8593464</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Y.-S.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>K.-C.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Y.-P.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>W.-C.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.-H.</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>C.-H.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>J.-M.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C.-C.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron</source>
          <volume>61</volume>
          <year>2005</year>
          <fpage>1855</fpage>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshino</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hakomori</surname>
              <given-names>S.-I.</given-names>
            </name>
          </person-group>
          <source>Biochemistry</source>
          <volume>21</volume>
          <year>1982</year>
          <fpage>928</fpage>
          <pub-id pub-id-type="pmid">7074061</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okamoto</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kanie</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y.-Y.</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Shimamura</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Chem. Biol.</source>
          <volume>12</volume>
          <year>2005</year>
          <fpage>677</fpage>
          <pub-id pub-id-type="pmid">15975513</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veerapen</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Brigl</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Garg</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cerundulo</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>L.R.</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Besra</surname>
              <given-names>G.S.</given-names>
            </name>
          </person-group>
          <source>Bioorg, Med. Chem. Lett.</source>
          <volume>19</volume>
          <year>2009</year>
          <fpage>4288</fpage>
          <pub-id pub-id-type="pmid">19502056</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akimoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Natori</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron Lett.</source>
          <volume>34</volume>
          <year>1993</year>
          <fpage>5593</fpage>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van den Berg</surname>
              <given-names>R.J.B.H.N.</given-names>
            </name>
            <name>
              <surname>Boltje</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Verhagen</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Litjens</surname>
              <given-names>R.E.J.N.</given-names>
            </name>
            <name>
              <surname>Van der Marel</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Overkleeft</surname>
              <given-names>H.S.</given-names>
            </name>
          </person-group>
          <source>J. Org. Chem.</source>
          <volume>71</volume>
          <year>2006</year>
          <fpage>836</fpage>
          <pub-id pub-id-type="pmid">16409007</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Komba</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ishida</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kiso</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <source>Bioorg. Med. Chem.</source>
          <volume>4</volume>
          <year>1996</year>
          <fpage>1833</fpage>
          <pub-id pub-id-type="pmid">9007268</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gervay-Hague</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ngyuen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hadd</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <source>Carbohydr. Res.</source>
          <volume>300</volume>
          <year>1997</year>
          <fpage>119</fpage>
        </element-citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meloncelli</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Lowary</surname>
              <given-names>T.L.</given-names>
            </name>
          </person-group>
          <source>Carbohydr. Res.</source>
          <volume>344</volume>
          <year>2009</year>
          <fpage>1110</fpage>
          <pub-id pub-id-type="pmid">19410241</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lam</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Gervay-Hague</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Carbohydr. Res.</source>
          <volume>337</volume>
          <year>2002</year>
          <fpage>1953</fpage>
          <pub-id pub-id-type="pmid">12433461</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Du</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Gervay-Hague</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Chem. Commun.</source>
          <volume>23</volume>
          <year>2007</year>
          <fpage>2336</fpage>
        </element-citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhat</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Gervay-Hague</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <source>Org. Lett.</source>
          <volume>13</volume>
          <year>2001</year>
          <fpage>2081</fpage>
          <pub-id pub-id-type="pmid">11418054</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goff</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mattner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Cantu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Teyton</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Bendelac</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Savage</surname>
              <given-names>P.B.</given-names>
            </name>
          </person-group>
          <source>J. Am. Chem. Soc.</source>
          <volume>126</volume>
          <year>2004</year>
          <fpage>13602</fpage>
          <pub-id pub-id-type="pmid">15493902</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xia</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Woodward</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>P.G.</given-names>
            </name>
          </person-group>
          <source>Tetrahedron</source>
          <volume>65</volume>
          <year>2009</year>
          <fpage>6390</fpage>
        </element-citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <note>
          <p>Peripheral blood mononuclear cells (PBMC) were obtained by Ficoll-hypaque centrifugation of leucocyte concentrates obtained from healthy volunteer blood donors. For ex vivo expansion of human <italic>i</italic>NKT cells, 4 million PBMC were cultured in wells of 24-well tissue culture plates in RPMI-1640 medium with 10% foetal calf serum and recombinant IL-2 (60 IU/mL) and IL-7 (5 ng/mL) (Peprotech). Glycolipids were solubilised in 100% DMSO and added directly to culture media to achieve a final concentration of 250 nM. Control wells received an amount of DMSO vehicle identical to that added with the glycolipids (0.00125%). Cultures were incubated for 8 days at 37 °C in a 5% CO<sub>2</sub> humidified incubator. Cultures were harvested and the cells stained with fluorochrome labelled monoclonal antibodies specific for CD3 and the <italic>i</italic>NKT cell TCR (6B11, BD Biosciences). Samples were also stained with propidium iodide to exclude dead cells, and a known number of Caltag fluorescent counting beads (Invitrogen) were added to the samples to allow quantitation of absolute cell numbers. The total number of <italic>i</italic>NKT cells (CD3<sup>+</sup>, 6B11<sup>+</sup>, PI negative lymphocytes) was calculated by normalising according to counting beads and the fold expansion values were calculated based on the initial number of <italic>i</italic>NKT cells. Data were collected on a FACSCalibur flow cytometer using CellQuest software (BD Biosciences).</p>
        </note>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <note>
          <p><italic>Selected data for new compounds</italic>. Compound <bold>8</bold>: <sup>1</sup>H NMR (CDCl<sub>3</sub>): <italic>δ</italic> 7.92–8.04 (10H, m, Ar-<italic>H</italic>), 7.10–7.64 (15H, m, Ar-<italic>H</italic>), 5.42–5.50 (2H, m, H-3<italic><sup>Cer</sup></italic>, H-4<italic><sup>Cer</sup></italic>), 5.02 (1H, d, <italic>J</italic><sub>1,2</sub> = 3.6 Hz, H-1), 4.72–4.84 (6H, m, 3 × C<italic>H</italic><sub>2</sub>Ph), 3.98 (1H, dd, <italic>J</italic><sub>2,3</sub> = 11.5 Hz, H-2), 3.75–3.90 (3H, m, H-4, H-3, H-1a<italic><sup>Cer</sup></italic>), 3.55 (1H, m, H-5), 3.68 (1H, dd, <italic>J</italic><sub>1a,1b</sub> = 10.4, <italic>J</italic><sub>1b,2</sub> = 8.6 Hz, H-1b<italic><sup>Ce</sup></italic><sup>r</sup>), 1.88 (2H, m, H-5a<italic><sup>Cer</sup></italic>, H-5b<italic><sup>Cer</sup></italic>), 1.27 (3H, d, <italic>J</italic><sub>5,6</sub> = 6.4 Hz, H-6), 1.24 (24H, m, C<italic>H</italic><sub>2</sub>), 0.89 (3H, t, C<italic>H</italic><sub>3</sub>); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): <italic>δ</italic> 99.5 (C-1); HRMS calcd for C<sub>59</sub>H<sub>73</sub>N<sub>3</sub>O<sub>9</sub> [M+Na]<sup>+</sup>: 990.5245, found 990.5248. Compound <bold>9</bold>: <sup>1</sup>H NMR (CD<sub>3</sub>OD): <italic>δ</italic> 4.73 (1H, d, <italic>J</italic><sub>1,2</sub> = 3.7 Hz, H-1), 3.91–3.96 (2H, m, H-3, H-4), 3.68–3.72 (1H, dd, <italic>J</italic><sub>1a,1b</sub> = 9.9, <italic>J</italic><sub>1b,2</sub> = 3.9 Hz, H-1a<italic><sup>Cer</sup></italic>), 3.61–3.68 (2H, m, H-4, H-3<italic><sup>Cer</sup></italic>, H-4<italic><sup>Cer</sup></italic>), 3.52–3.55 (1H, dd, <italic>J</italic><sub>2,3</sub> = 6.0 Hz, H-2), 3.43–3.49 (1H, m, H-5), 3.39–3.42 (1H, dd, <italic>J</italic><sub>1b,2</sub> = 8.6 Hz, H-1b<italic><sup>Cer</sup></italic>), 3.35 (1H, m, H-2<italic><sup>Cer</sup></italic>), 1.89 (2H, m, H-5a<italic><sup>Cer</sup></italic>, H-5b<italic><sup>Cer</sup></italic>), 1.28 (3H, d, <italic>J</italic><sub>5,6</sub> = 6.4 Hz, H-6), 1.24 (24H, m, C<italic>H</italic><sub>2</sub>), 0.89 (3H, t, C<italic>H</italic><sub>3</sub>); <sup>13</sup>C NMR (75 MHz, CD<sub>3</sub>OD): <italic>δ</italic> 102.5 (C-1); HRMS calcd for C<sub>24</sub>H<sub>49</sub>NO<sub>7</sub> [M+Na]<sup>+</sup>: 486.3403, found 486.3309. Compound <bold>11</bold>: <sup>1</sup>H NMR (CDCl<sub>3</sub>): <italic>δ</italic> 7.36–7.86 (10H, m, Ar-H), 5.60 (1H, dd, <italic>J</italic><sub>3,4</sub> = 4.8, <italic>J</italic><sub>3,2</sub> = 6.8 Hz, H-3<italic><sup>Cer</sup></italic>), 5.51 (1H, ddd, <italic>J</italic><sub>4,5a</sub> = 4.2, <italic>J</italic><sub>4,5b</sub> = 8.5 Hz, H-4<sup>Cer</sup>), 4.82 (1H, d, <italic>J</italic><sub>1,2</sub> = 2.8 Hz, H-1), 3.88–4.00 (3H, m, H-2, H-4, H-5), 3.62–3.80 (3H, m, H-3, H-2<italic><sup>Cer</sup></italic>, H-1a<italic><sup>Cer</sup></italic>), 3.71 (1H, dd, <italic>J</italic><sub>1a,1b</sub> = 10.4, <italic>J</italic><sub>1b,2</sub> = 6.5 Hz, H-1b<italic><sup>Cer</sup></italic>), 1.76–1.91 (2H, m, H-5a<italic><sup>Cer</sup></italic>, H-5b<italic><sup>Cer</sup></italic>), 1.10–1.43 (24 H, m, C<italic>H</italic><sub>2</sub>), 1.07 (3H, d, <italic>J</italic><sub>5,6</sub> = 6.6 Hz, H-6), 0.85 (3H, t, C<italic>H</italic><sub>3</sub>); <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): <italic>δ</italic> 100.9 (C-1); HRMS calcd for C<sub>38</sub>H<sub>55</sub>N<sub>3</sub>O<sub>10</sub> [M+Na]<sup>+</sup>: 720.3836, found 720.3811. Compound <bold>4a</bold>: HRMS calcd for C<sub>44</sub>H<sub>83</sub>NO<sub>8</sub> [M+Na]<sup>+</sup>: 776.6013, found 776.6011. Compound <bold>4b</bold>: HRMS calcd for C<sub>42</sub>H<sub>83</sub>NO<sub>9</sub> [M+Na]<sup>+</sup>: 768.5962, found 768.5941. Compound <bold>4c</bold>: HRMS calcd for C<sub>48</sub>H<sub>95</sub>NO<sub>8</sub> [M+Na]<sup>+</sup>: 836.6956, found 836.6953. Compound <bold>4d</bold>: HRMS calcd for C<sub>50</sub>H<sub>99</sub>NO<sub>8</sub> [M+Na]<sup>+</sup>: 864.7268, found 864.7240.</p>
        </note>
      </ref>
      <ref id="bib41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>K.O.</given-names>
            </name>
            <name>
              <surname>Im</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Molano</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dutronc</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Illarionov</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Forestier</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Arias</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yamamura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>Y.T.</given-names>
            </name>
            <name>
              <surname>Besra</surname>
              <given-names>G.S.</given-names>
            </name>
            <name>
              <surname>Porcelli</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <source>Proc. Natl. Acad. Sci. U.S.A.</source>
          <volume>102</volume>
          <year>2005</year>
          <fpage>3383</fpage>
          <pub-id pub-id-type="pmid">15722411</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgements</title>
      <p>G.S.B. acknowledges support in the form of a Personal Research Chair from Mr. James Badrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow, the Medical Council and The Wellcome Trust (084923/B/08/7). S.A.P. and G.B. were supported by NIH/NIAID grant AI45889. Core resources that facilitated flow cytometry were supported by the Einstein Center for AIDS Research (AI 051519) and the Einstein Cancer Center (CA 13330). The NMR spectrometers used in this research were funded in part through Birmingham Science City with support from Advantage West Midlands (AWM) and part-funded by the European Regional Development Fund (ERDF).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p><italic>Ex vivo expansion of human iNKT cells by α-<sc>l</sc>-fucosylceramides</italic>. PBMC from four different donors were stimulated with the indicated glycolipids at a concentration of 250 nM in the presence of low levels of exogenous IL-2 and IL-7. At day 8, cultures were harvested and analysed by flow cytometry using monoclonal antibodies specific for CD3 and for the invariant TCRα chain expressed by <italic>i</italic>NKT cells (6B11). (A) Dot plots showing relative levels of CD3<sup>+</sup> 6B11<sup>+</sup><italic>i</italic>NKT cells are shown for one representative donor. Numbers in upper right quadrant indicate percentages of total lymphocytes that are <italic>i</italic>NKT cells. (B) Absolute numbers of <italic>i</italic>NKT cells in the cultures were determined by flow cytometry using fluorescent counting beads, and the values of <italic>i</italic>NKT cell fold expansion were determined by dividing by the input number of <italic>i</italic>NKT cells.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Scheme 1</label>
      <caption>
        <p>(a) Me<sub>2</sub>S, 2-Cl-pyridine, Tf<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>; (b) dimethyl(methylthio)sulfonium triflate (DMTST), CH<sub>2</sub>Cl<sub>2</sub>, 0 °C-rt.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Scheme 2</label>
      <caption>
        <p>(a) NIS/TfOH, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C to −20 °C, 68%; (b) NaOMe/MeOH, 92%; (c) H<sub>2</sub>, Pd, 76%.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>Scheme 3</label>
      <caption>
        <p>(a) TBAI, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) Dowex 50WX8-200, MeOH, rt, 62% over two steps; (c) NaOMe/MeOH, quantitative; (d) H<sub>2</sub>, Pd, MeOH, 80%; (e) C<sub>25</sub>H<sub>51</sub>COCl or C<sub>23</sub>H<sub>47</sub>COC1, THF, NaOAc, 78–80%.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
  </floats-group>
</article>